Scholar Rock Holding Corporation (SRRK) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $46.75 (+0.30%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 4, 2026 | Allison Bratzel | Piper Sandler | $58.00 | +24.1% |
| Mar 3, 2026 | Etzer Darout | Barclays | $53.00 | +13.4% |
| Mar 3, 2026 | Srikripa Devarakonda | Truist Financial | $55.00 | +17.6% |
| Jan 26, 2026 | Andres Maldonado | H.C. Wainwright | $58.00 | +24.1% |
| Jan 7, 2026 | Michael Yee | UBS | $60.00 | +28.3% |
| Dec 17, 2025 | Etzer Darout | Barclays | $52.00 | +11.2% |
| Sep 24, 2025 | Allison Bratzel | Piper Sandler | $51.00 | +9.1% |
| Sep 24, 2025 | Etzer Darout | Barclays | $44.00 | -5.9% |
| Nov 13, 2024 | Etzer Darout | BMO Capital | $39.00 | -16.6% |
| Oct 15, 2024 | Allison Bratzel | Piper Sandler | $42.00 | -10.2% |
| Oct 11, 2024 | Etzer Darout | BMO Capital | $38.00 | -18.7% |
| Jun 13, 2024 | Etzer Darout | BMO Capital | $31.00 | -33.7% |
| May 23, 2024 | Allison Bratzel | Piper Sandler | $28.00 | -40.1% |
| May 23, 2024 | Etzer Darout | BMO Capital | $29.00 | -38.0% |
Top Analysts Covering SRRK
SRRK vs Sector & Market
| Metric | SRRK | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 12 | 8 | 18 |
| Target Upside | +21.0% | +1150.2% | +14.9% |
| P/E Ratio | -14.18 | 6.88 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $2M | $17M | $27M | 11 |
| 2027-03-31 | $18M | $18M | $18M | 1 |
| 2027-06-30 | $35M | $35M | $35M | 1 |
| 2027-09-30 | $53M | $53M | $53M | 1 |
| 2027-12-31 | $73M | $73M | $73M | 1 |
| 2028-03-31 | $81M | $81M | $81M | 1 |
| 2028-06-30 | $97M | $97M | $97M | 1 |
| 2028-09-30 | $115M | $115M | $115M | 1 |
| 2028-12-31 | $135M | $135M | $135M | 1 |
| 2029-12-31 | $332M | $561M | $1.07B | 5 |
| 2030-12-31 | $499M | $843M | $1.61B | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-3.72 | $-3.15 | $-1.78 | 12 |
| 2027-03-31 | $-0.73 | $-0.73 | $-0.73 | 4 |
| 2027-06-30 | $-0.67 | $-0.67 | $-0.67 | 4 |
| 2027-09-30 | $-0.56 | $-0.56 | $-0.56 | 4 |
| 2027-12-31 | $-0.58 | $-0.58 | $-0.58 | 4 |
| 2028-03-31 | $-0.36 | $-0.36 | $-0.36 | 5 |
| 2028-06-30 | $-0.26 | $-0.26 | $-0.26 | 5 |
| 2028-09-30 | $-0.15 | $-0.15 | $-0.15 | 5 |
| 2028-12-31 | $-0.03 | $-0.03 | $-0.03 | 5 |
| 2029-12-31 | $-0.58 | $-0.26 | $-0.12 | 3 |
| 2030-12-31 | $0.67 | $1.44 | $3.13 | 3 |
Frequently Asked Questions
What is the analyst consensus for SRRK?
The consensus among 12 analysts covering Scholar Rock Holding Corporation (SRRK) is Buy with an average price target of $56.57.
What is the highest price target for SRRK?
The highest price target for SRRK is $60.00, set by Michael Yee at UBS on 2026-01-07.
What is the lowest price target for SRRK?
The lowest price target for SRRK is $28.00, set by Allison Bratzel at Piper Sandler on 2024-05-23.
How many analysts cover SRRK?
12 analysts have issued ratings for Scholar Rock Holding Corporation in the past 12 months.
Is SRRK a buy or sell right now?
Based on 12 analyst ratings, SRRK has a consensus rating of Buy (2.00/5) with a +21.0% upside to the consensus target of $56.57.
What are the earnings estimates for SRRK?
Analysts estimate SRRK will report EPS of $-3.15 for the period ending 2026-12-31, with revenue estimated at $17M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.